December 3rd & 4th, 2024
IN-PERSON | LILLE, FR
December 11th& 12th 2024
ONLINE MEETINGS
Dec 3rd & 4th, 2024
IN-PERSON | LILLE, FR
Dec 11th& 12th, 2024
ONLINE MEETINGS
Home » Discover Lille
The Lille Region is the 3rd ranked life sciences cluster in France. The main areas of expertise in the Hauts-de-France region are metabolic diseases, ageing diseases, nutrition and blood related products. The pharma-biotech sector in Northern France enjoys the presence of both big companies (AstraZeneca, Bayer, GSK…), a dense network of innovative start-ups (AlzProtect, ImaBiotech, Innobiochips…) and dynamic midsize biopharmaceutical companies (Diagast, Genfit, Genoscreen, LFB…).
The pharma-biotech sector in the Hauts-de-France region:
– Export turnover of more than €3 billion
– Regional turnover of €6 billion (11% of the €53
billion national turnover)
– 11,600 jobs (11% of jobs in France in this sector)
With more than 1,000 international actors from 35+ countries, such as big pharma, emerging and small biotech, diagnostic companies, pre-seed / seed / Series A investors, as well as professionals from tech transfer, academia and research institutions, BioFIT is the leading partnering event in Europe for technology transfer, academia-industry collaborations and early-stage innovation deals in the field of Life Sciences. BioFIT is also the European marketplace for pre-seed, seed and Series A investment rounds in Life Sciences.
Learn more
Organised by:
WITH THE SUPPORT OF:
INSTITUTIONAL PARTNERS:
"*" indicates required fields
Lille Grand Palais
1, Boulevard des Cités Unies
59777 Lille, FRANCE
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
WARNING: Some fraudulent companies are supposedly providing the attendees list of BioFIT. And some are passing themselves off as being BioFIT organisation members and asking you to pay. Please note that the BioFIT team will never sell you the BioFIT attendees list and never ask for your bank account details to make you pay for hotel bookings, exhibition fees or others, and certainly not over the phone.Please be extremely vigilant.